ATH 14.3% 0.3¢ alterity therapeutics limited

Ann: Prana Doses 1st Patient in PBT2 Alzheimers E, page-5

  1. 5,887 Posts.
    lightbulb Created with Sketch. 150
    re: Ann: Prana Doses 1st Patient in PBT2 Alzh... "given the support expressed from the physicians involved"
    That sure is a very positive note. Not for sure yet, but PBT2 has demonstrated rescue of damaged neurons, strengthening of the interconnecting dendrites, rescue of damaged synapses, balancing iron overload, balancing of essential transition metals, prevention of hyperphosphorylation of tau, clearance of tau tangles and clearance of amyloid plaques and probably a few things l have forgotten.
    PBT2 has also demonstrated rapid cognition gains in a 12 week clinical trial.
    I will be very surprised if we don't have the first disease modifying drug for Alzheimer's here.
    Good luck to holders

    Not a medical professional or investment adviser.




























 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(14.3%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.18K 3.279M

Buyers (Bids)

No. Vol. Price($)
38 52064257 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126697935 22
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.